Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 87 results for "harvard bone marrow initiative"

First area cell transplantation center
Harvard University Gazette

First area cell transplantation center

T he Harvard Stem Cell Institute (HSCI), three of Harvard's clinical affiliates, and a biopharmaceutical company have formed an unusual collaboration to establish the Boston Autologous Islet Replacement Program (BAIRT) to accelerate a cure for ... Harvard University Gazette, 1 month ago

6 images for harvard bone marrow initiative

GlobalSpec, 1 month ago
Harvard University Gazette, 1 month ago
Livemint.com, 6 months ago
Medical Xpress, 5 months ago
Daiji World, 5 months ago
SPi World News, 6 months ago
PharmaVOICE

Boehringer Ingelheim inks research pact with Harvard scientists to discover novel treatments for severe fibrotic diseases

Boehringer Ingelheim has established a research collaboration with the Harvard Stem Cell Institute's - Harvard Fibrosis Network to discover new ways of treating fibrotic diseases such as idiopathic pulmonary fibrosis (IPF), chronic kidney disease ...
 PharmaBiz1 month ago BOEHRINGER INGELHEIM : and Harvard scientists establish a research alliance to find novel treatments for severe fibrotic diseases  4 Traders1 month ago Boehringer Ingelheim and Harvard Scientists to Find Novel Treatments  CPhI.cn1 month ago Boehringer IngelheimAnd Harvard Scientists Establish A Research Alliance To Find Novel Treatments For Severe Fibrotic Diseases  BioSpace1 month ago
[x]  

Global Blood Therapeutics Announces New Clinical Data that Continue to Support Safety and Efficacy Profile of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease

90-Day Data Show Sustained Treatment Response and Support Company's Plan to Initiate Pivotal Trial This Year Results Presented at European Hematology Association's (EHA) 21st Congress Company to Host Webcast Today at 1:30 p.m. CEST/7:30 a.m. ET to ...
 Benzinga.com1 month ago Global Blood Therapeutics Stock Surges on Promising Sickle Cell Drug Results  BioSpace1 month ago GLOBAL BLOOD THERAPEUTICS : Announces New Clinical Data that Continue to Support Safety and Efficacy Profile of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease  4 Traders1 month ago
[x]  

Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis

, 1 Lucia Kubovcakova , 1 Ronny Nienhold , 1 Jakub Zmajkovic , 1 Sara C. Meyer , 1 Hui Hao-Shen , 1 Florian Geier , 2 Stephan Dirnhofer , 3 Paola Guglielmelli , 4 Alessandro M. Vannucchi , 4 Jelena D. Milosevic Feenstra , 5 Robert ...
 Journal of Experimental Medicine2 weeks ago
Physicians Weekly

Antiretroviral Therapy: Not Enough for HIV-Associated Arterial Inflammation?

Additional immune-system-modulatory approaches may help reduce risk of cardiovascular disease. Initiating antiretroviral therapy (ART) soon after diagnosis of an HIV infection did not prevent the progression of significant arterial inflammation in ...
 PharmaceuticalProcessing2 months ago ART alone not sufficient to reduce arterial inflammation among HIV-infected patients, study finds  News-Medical.Net2 months ago Antiretroviral therapy may not be enough to reduce HIV-associated arterial inflammation  Biocompare2 months ago
[x]  
Stanford Report

Group of rare blood cancers respond to new treatment pioneered by Stanford physician

By a News Reporter-Staff News Editor at Drug Week A global trial of an oral medication called midostaurin indicates that the drug can produce partial or complete resolution of organ damage in 60 percent of patients with a group of rare blood cancers ...
 Pharmacy Choice1 week ago Advanced systemic mastocytosis responds to new treatment  Ecancer Medicalscience3 weeks ago SYSTEMIC MASTOCYTOSIS RESPONDS TO NEW DRUG  International Business Times3 weeks ago Treating Rare Blood Cancers  Bioscience Technology Online3 weeks ago
[x]  

Paper Alert: Autoimmunity in Another C9ORF72-Deficient Mouse Strain

Hexanucleotide expansions in an intron of C9ORF72 are linked to amyotrophic lateral sclerosis and frontotemporal dementia, but how these expansions trigger disease is largely a mystery. As described in Science Translational Medicine on July 13, yet ...
 Alzheimer Research Forum1 week ago

Immunotherapy benefits relapsed stem cell transplant recipients

EurekAlert! provides embargoed and breaking science news you can't afford to miss. EurekAlert! offers a one-stop science news distribution service you can trust. EurekAlert! is a service of the American Association for the Advancement of Science. ...
 EurekAlert!2 weeks ago

PAs, NPs Seizing Key Leadership Roles in HM Groups, Health Systems

S ince hospital medicine 's early days, hospitalist physicians have worked alongside physician assistants (PAs) and nurse practitioners (NPs). Some PAs and NPs have ascended to positions of leadership in their HM groups or health systems, in some ...
 Hospitalist.org2 weeks ago
Beijing Review

Fighting Leukemia

A woman in Henan Province donates her hematopoietic stem cells to a leukemia patient on November 16, 2015 (XINHUA) After more than three hours of collection, 299 ml of hematopoietic stem cell suspension was extracted from the body of Ji Guochen, ...
 Beijing Review1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - harvard bone marrow initiative
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less